/Investor DB

Apollo Health Ventures — 2024 Investments

3 investments dated 2024 · listed companies and verified rows first · show all

Refoxyrefoxy.cominDec 2024

Refoxy is a science-driven company focused on drug discovery, medicinal chemistry, and bioinformatics.

BiotechDeep TechHealthtechLongevity

Victor Bustos(Co-Founder & CEO)inWolfgang Link(Scientific Co-founder & Advisor)inAndrew Pierce(Chief Science Officer)in

Co-investorsKorify CapitalBoehringer Ingelheim Venture FundHTGF

Vandriavandria.cominSeries A · Aug 2024 · $10M

Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics.

BiotechHealthtechLongevityMedical DevicesLausanne, CH

Patrick Aebischer(Co-founder)Pénélope Andreux(Head of Research (mitochondrial research and development))inKlaus Dugi(Chief Medical Officer / Medical Leadership)inPeter(Business Development & Entrepreneurship Leadership)Leila(Operations Leadership)Anke Post(Chief Medical Officer / Neuroscience Leadership)

Co-investors+ND CapitalDolby Family VenturesLevensohn Venture Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Booster Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.